期刊文献+

杜氏利什曼原虫NH36基因的克隆及其在大肠杆菌中的表达

Cloning and expression of NH36 gene from Leishmania donovani SC10H2 strain in Escherichia coli
下载PDF
导出
摘要 应用RT-PCR技术扩增并克隆杜氏利什曼原虫(Leishmania donovani)NH36编码基因,经鉴定及序列分析,构建其原核重组表达载体,经IPTG诱导表达,SDS-PAGE和Western-blotting鉴定其表达产物。结果显示,获得的NH36开放阅读框为945 bp,编码314个氨基酸残基,与GenBank上发表的国际标准株NH36编码基因序列以及氨基酸序列同源性分别为88.57%(837/945)和89.17%(280/314)。表达蛋白为36 ku,经1 mol/L IPTG诱导6 h后的表达量最高;薄层扫描显示表达的蛋白占菌体蛋白总量的57%;该蛋白可被抗杜氏利什曼原虫的多克隆抗体血清识别。 The NH36 gene was amplified from Leishrnania donovani by RT-PCR,and then cloned and sequenced. A recombinant plasmid pET-28a-Ld-NH36 was constructed and expressed by induction with IPTG. Sequencing result demonstrated that the open reading frame(()RF) of the NH36 gene was 945 bp, encoding 314 amino acid residues, and the homologies of the nucleotide sequence and amino acid sequence to the published sequence in GenBank were 88.57 % (837/945)and 89.17 % (280/314), respectively. SDS- PAGE indicated that the interest fusion protein was 36 ku,with peak expression 6 h after induction with 1 mol/L of IPTG. Western-blotting result showed that it was specifically recognized by polyclonal antibodies against L. donovani.
出处 《中国兽医科学》 CAS CSCD 北大核心 2007年第3期209-213,共5页 Chinese Veterinary Science
关键词 杜氏利什曼原虫 NH36 克隆 序列分析 表达 大肠杆菌 Leishmania donovani NH36 cloning sequence analysis expression Escherichia coli
  • 相关文献

参考文献13

  • 1HASSAN H F,COOMBS G H. Purine and pyrimidine metabolism in parasitic protozoa [J] FEMS Microbiol Rev, 1988,4(1) :47-83.
  • 2LA FON S W, NELSON D J, BERENS R L, et al. Purine and pyrimidine salvage pathways in Leishmania donovani[J]. Biothem Pharmacol,1982,31(2):231-238.
  • 3SUNDAR S, RAI M. Laboratory diagnosis of visceral leishmaniasis[J]. Clin Diagn Lab Immunol, 2002,9(5 ) : 951-958.
  • 4WANG Cui-li,RAJASEKARIAH G R,MARTIN S K. A non-specific nucleoside hydrolase from Leishmania donovani:implications for purine salvage by the parasite[J]. Gene, 2001,280(1/2):153-162.
  • 5MARR J J ,BERENS R L,NELSON D J. Purine metabolism in Leishmania donovani and Leishmania braziliensis[J ]. Biochim Biophys Acta, 1978,544(2) :360-371.
  • 6PALATNIK DE SOUSA C B, GOMES E M, PARAGUAI DE SOUZA E,et al. The FmL(Fucose Mannose Ligand) of Leishmania donovani:a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar[J]. Rev Soc Bras Med Trop, 1996,29(2) : 153-163.
  • 7PALATNIK DE SOUSA C B, DUTRA H S, BOROJEVIC R.Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the fucose-mannose ligand (FmL)[J]. Acta Trop,1993,53(1) :59-72.
  • 8AGUILAR-BE I, DA SILVA ZARDO R, PARAGUAI DE SOUZA E, et al. Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis[J]. Infect Immun, 2005,73 (2) :812-819.
  • 9GAMBOA-LEON R, PARAGUAI DE SOUZA E, BORJA-CABRERA G P, et al. Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani[J]. Vaccine ,2006,24(22) :4863-4873.
  • 10SANTOS W R,DE LIMA V M,PARAGUAI DE SOUZA E,et al. Saponins, IL12 and BCG adjuvant in the FmL-vaccine formulation against murine visceral leishmaniasis [J]. Vaccine ,2002,21(1/2 ):30-43.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部